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In a series of 116 Salmonella enterica Newport isolates that
included 64 multidrug-resistant (MDR) isolates, automated ribo-
typing and pulsed-field gel electrophoresis (PFGE) discriminat-
ed MDR S. Newport with a sensitivity of 100% and 98% and
specificity of 76% and 89%, respectively. Clustering of PFGE
patterns (but not ribotyping) linked human and bovine cases.
Automated ribotyping rapidly identified the MDR strain, and
PFGE detected associations that aided epidemiologic investiga-
tions.
A
n eight-drug resistant strain of Salmonella enterica
serotype Newport (multidrug-resistant [MDR] S.
Newport) characterized by resistance to at least ampicillin,
cephalothin, chloramphenicol, clavulanic acid, streptomycin,
sulfamethoxazole, tetracycline, and ceftriaxone (intermediate
to complete) recently identified by the National Antimicrobial
Resistance Monitoring System (NARMS), Centers for Disease
Control and Prevention (CDC), (1) is an example of the emer-
gent problem of antibiotic resistance. However, only a few state
laboratories routinely perform susceptibility testing on enteric
organisms, particularly in a format comparable to that
employed by NARMS. Rapid identification of drug resistance
is critical for preventing and treating diseases and for epidemi-
ologic analysis (2). 
Pulsed-field gel electrophoresis (PFGE) testing is more
common at state public health laboratories; 50 such laborato-
ries participate in CDC’s PFGE surveillance program,
PulseNet. In PulseNet, participants submit PFGE data on E.
coli  O157:H7,  Salmonella spp.,  Shigella  spp., and Listeria
monocytogenes to a national database (3). Because PulseNet
laboratories follow a standardized protocol, PFGE patterns can
be compared reliably within the network and associations made
promptly among isolates that may be few in number and wide-
ly separated geographically. 
However, the clonal nature or inherent genetic variability of
bacteria may limit the ability of PFGE either to link isolates or
to detect relatedness among a set of isolates from a single out-
break (4). In some organisms, such as Shigella spp. and
Campylobacter spp., PFGE patterns vary considerably, and dif-
ferences in banding patterns can occur among isolates that are
epidemiologically linked (5). In other organisms, such as
Salmonella serotype Enteritidis, variability of PFGE patterns is
limited, and banding patterns can be indistinguishable among
isolates that are not epidemiologically linked. Often, supple-
mental methods are needed to detect an association among iso-
lates because of their apparent clonal characteristics (6).
Therefore, PFGE databases must contain patterns from a suffi-
cient number of isolates of a species representative of circulat-
ing strains to enable accurate interpretation of relatedness. 
In Massachusetts, S. Newport isolates analyzed by PFGE
have shown a high degree of variability. Ribotyping has been
reported to be less discriminatory than PFGE (7) but can pro-
vide information that identifies real associations undetected
solely by PFGE analysis, particularly when epidemiologic data
are limited (8). We evaluated the usefulness of PFGE and auto-
mated ribotyping, independently and together, to monitor and
characterize the MDR strain of S. Newport in Massachusetts. 
The Study
Specimens of Salmonella spp. submitted to the State
Laboratory Institute as pure cultures or isolates from fresh stool
samples submitted in Meridian Para-Pak C & S medium
(Meridian Bioscience, Inc., Cincinnati, OH) were serotyped by
the Kaufmann-White scheme, according to CDC protocols (9).
After an increase in the incidence of S. Newport , the
Massachusetts Department of Public Health initiated enhanced
surveillance for this bacterium. In December 2000, we posted
patterns MA-JJP0034 and MA-JJP0070 on the PulseNet list-
serv and asked other states to determine detection of S.
Newport (CDC PulseNet patterns JJP.X01.0014 and
JJP.X01.0181, respectively). In response, Oklahoma,
Minnesota, Maine, and Vermont posted similar or indistin-
guishable isolates. In January 2001, S. Newport was isolated
from a stool specimen from an employee at a Massachusetts
farm that also reported diarrheal illness in cows. Investigators
from the Massachusetts Department of Public Health and the
Massachusetts Department of Food and Agriculture, Bureau of
Animal Health, with assistance from CDC, visited farms and
auction houses to obtain stool specimens from cows and calves
exhibiting diarrheal illness. Isolates identified as S. Newport
were tested by PFGE and automated ribotyping, and for antimi-
crobial resistance.
All  S. Newport isolates were tested for resistance to
amikacin, ampicillin, amoxicillin/clavulanic acid, apramycin,
cefoxitin, ceftiofur, ceftriaxone, cephalothin, chloramphenicol,
ciprofloxacin, gentamicin, kanamycin, nalidixic acid, strepto-
mycin, sulfamethoxazole, tetracycline, and trimethoprim/sul-
phamethoxazole by using the Trek Diagnostics Sensititre
CMV1UIL (Trek Diagnostic Systems, Inc., Cleveland, OH)
plate. Isolates categorized as MDR S. Newport were resistant to
at least ampicillin, cephalothin, chloramphenicol, clavulanic
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Massachusetts, USAacid, streptomycin, sulfamethoxazole, and tetracycline, and
demonstrated complete or intermediate resistance to ceftriax-
one. An E. coli strain, ATTC 25922, was used as a control
organism during each susceptibility test run.
PFGE was performed on all S. Newport isolates, according
to previously described methods (10). Automated ribotyping
was performed by using the Riboprinter Microbial
Characterization System (DuPont Qualicon, Wilmington, DE),
according to the manufacturer’s protocol. Briefly, a sweep of
pure S. Newport cells from each test isolate was suspended in
a 12- x 75-mm Falcon tube in sample buffer to 20% transmit-
tance in a Vitek Colorimeter (bioMérieux, Durhan, NC). Thirty
microliters of each suspension was transferred to one well in an
eight-well sample carrier and heat treated to 80°C for 30 min;
5 µL of lysis buffers A and B was then added. The sample car-
rier was then placed in the Riboprinter for automated process-
ing, which included the following steps: DNAextraction, PvuII
restriction and electrophoresis through a 1% agarose gel, DNA
transfer, and hybridization to a nylon membrane. The DNAwas
probed with a sulfonated 6.7 Kb probe derived from the E. coli
rRNA operon, which was detected with alkaline
phosphatase–labeled anti-sulfonated anti-DNA antibodies.
Ribotype images were captured by a charge-coupled device
camera and  compared for similarity to images in a PvuII data-
base of 272 Salmonella patterns of 138 serotypes (11).
PFGE patterns were analyzed with Molecular Analyst
Software Version 1.11 (Bio-Rad Laboratories, Hercules, CA)
by using the Dice coefficient with a band position tolerance of
1.5%. This method considers only the presence or absence of a
band. All S. Newport patterns were compared with pattern MA-
JJP0034, the first pattern of MDR S. Newport that appeared in
Massachusetts. Patterns with a similarity coefficient of >0.85
relative to pattern MA-JJP0034 were designated in the analysis
as MDR S. Newport by PFGE (D. Boxrud, pers. comm.).
Ribotype patterns were analyzed by the Riboprinter soft-
ware, using the Pearson coefficient against a database of unique
patterns of Salmonella serotypes. In this study, the S. Newport
ribotypes with a similarity >0.85. were included in the MDR
ribogroup. Sensitivity and specificity of the PFGE and ribotyp-
ing methods to identify MDR S. Newport were calculated and
compared to the test results obtained by serotyping and antibi-
otic sensitivity testing for the 130 S. Newport isolates (12). 
Conclusions
One hundred sixteen S. Newport isolates from 300 human
specimens and 14 S. Newport isolates from 50 bovine speci-
mens were identified by serotyping at the State Laboratory
Institute during the study period; 64 isolates were identified as
MDR S. Newport (50 [43%] of 116 human isolates and all 14
bovine isolates). In addition to the eight-drug resistance pattern
of the MDR isolates, 11 of 50 human isolates and 11 of 14
bovine isolates were resistant to kanamycin.
Two ribotype patterns, D-81 and D-82, designated as S.
Newport in the Riboprinter database, were associated with the
130 S. Newport serotyped isolates (Figure 1). The 64 MDR S.
Newport isolates, 50 human isolates, and 14 bovine isolates,
matched only to ribotype pattern D-81. Sixteen of 66 pansus-
ceptible S. Newport human isolates also were identified as D-
81 ribotype pattern. The remaining 50 pansusceptible S.
Newport isolates were identified as D-82 ribotype pattern
(Table). Using pattern D-81, ribotyping had a sensitivity of
100% and a specificity of 76% in identifying MDR S. Newport
among S. Newport isolates. 
Among the 130 human and bovine S. Newport isolates were
58 PFGE patterns of XbaI digests (Figure 2). Eight PFGE pat-
terns were associated with 64 MDR S. Newport isolates (Figure
3). Two of the 66 pansusceptible isolates smeared by PFGE
were not interpretable, leaving 64 isolates for PFGE analysis.
The most common PFGE pattern was MA-JJP0034, which
appeared in 41 (64%) of 64 of the MDR S. Newport isolates.
MA-JJP00015 was the most common pattern among the pan-
susceptible isolates, being found in 7 (11%) of 64 isolates.
When the S. Newport isolates were analyzed against PFGE pat-
tern 34, all MDR S. Newport isolates and 7 of 64 pansuscepti-
ble S. Newport isolates had a similarity coefficient of >0.85.
Thus, PFGE had a sensitivity of 98% and a specificity of 89%
when this pattern was used to screen this set of isolates. 
The 64 MDR S. Newport, among a sample of 130 S.
Newport isolates, were correctly identified by comparing the
sensitivity and specificity of PFGE and automated ribotyping
to conventional serotyping and antibiotic susceptibility test
results. The sensitivity of each method was >98%. The speci-
ficity of PFGE and automated ribotyping was 89% and 76%,
respectively, with no false-negative results, and 11% and 24%,
respectively, of S. Newport isolates misidentified (false posi-
tive) as the MDR strain.
Automated ribotyping was a rapid means of subtyping S.
Newport and distinguishing the MDR strain from non-MDR
strains by using the Riboprinter PvuII database. This capability
is important because most often Salmonella isolates are submit-
ted to state laboratories and characterized to the O antigen
level, not the species level. Further, serotyping performed at a
state public health laboratory to define the Salmonella species
requires a minimum of 2 days, and for biphasic Salmonella
species, such as S. Newport a minimum of 4 days (9). PFGE
was useful in distinguishing associations within the isolates of
S. Newport, which allowed for identification of potential epi-
demiologically related events, such as the PFGE pattern of
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Figure 1. Ribotype patterns for Salmonella Newport.MDR  S. Newport common among a subset of bovine and
human isolates. After a pure culture isolate is obtained, turn-
around times for PFGE and ribotyping testing are approximate-
ly 24 h and 8 h, respectively; however, serotype identification
often is required for interpretation of PFGE test results,
depending on the organism, which can lengthen turnaround for
final results by 1 or more days. 
Both automated ribotyping and PFGE rely on existing data-
bases of images from individual isolates to characterize DNA
fingerprints. As data from more strains are added to databases,
characterizing similarities or differences between isolates
becomes easier. Because the fingerprint database of the
PulseNet program is extensive and PFGE is more discriminato-
ry that ribotyping, PFGE provides a more robust tool in charac-
terizing the development of emerging pathogens. 
These data suggest that PFGE and ribotyping can be used
together to provide rapid identification of the MDR strain of S.
Newport. These methods offer important capabilities for labo-
ratory-based surveillance for public health purposes; however,
automated ribotyping is very costly and should be used in a
public health laboratory only if justified by appropriate cost-
benefit analysis. Furthermore, these data support the need for
strengthening public health laboratory infrastructure to facili-
tate early detection of infectious disease risks. 
Dr. Fontana is director of the Pulsed Field Gel Electrophoresis
and Antimicrobial Resistance Laboratory at the Massachusetts
Department of Public Health/State Laboratory Institute. With the sup-
port of the State Laboratory Institute and epidemiologists in the
Division of Communicable Disease, Dr. Fontana established the
Antimicrobial Resistance Surveillance Laboratory in 1999, which per-
forms susceptibility testing on invasive Streptococcus pneumoniae,
vancomycin resistant enterococci, Salmonella spp., Shigella spp., and
Escherichia coli O157:H7. 
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Table. Sensitivity and specificity of PFGE versus. ribotyping in identifying MDR Salmonella Newport
a 
PFGE of S. Newport  Ribotyping of S. Newport 
PFGE pattern MA-JJP0034  MDR  Not MDR  Total  D-81 ribotype  MDR  Not MDR  Total 
Yes
b  63  7  70  Yes  64  16  80 
No  1  57  58  No  0  50  50 
  64  64
c  128    64  66  130 
aPFGE, pulsed-field gel electrophoresis; MDR, multidrug resistant. 
b>85% relatedness to MA-JJP0034.  
cTwo pansusceptible isolates smeared by PFGE. 
Figure 2. Dendrogram of unique pulsed-field gel electrophoresis pat-
terns of Salmonella Newport. The 58 patterns represent all patterns
received at the State Laboratory Institute during April 1999–April 2001.
* indicates multidrug-resistant S. Newport patterns. 
Figure 3. Pulsed-field gel electrophoresis patterns of XbaI-digested
multidrug-resistant Salmonella Newport. Lane 2, pattern MA-JJP0036;
lane 3, pattern MA-JJP 0027; lane 6, pattern MA-JJP0062; lane 7, pat-
tern MA-JJP0077; lane 8, pattern MA-JJP0089; lane 9, pattern MA-
JJP0034; lane 11, pattern MA-JJP0050; lane 13, pattern MA-JJP0070.Emerging Infectious Diseases • Vol. 9, No. 4, April 2003 499
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